Guizhou Zirui Technology Co., Ltd. appears in FDA premarket records as the applicant for two substantially equivalent 510(k) decisions issued on the same day, 11 September 2026. The filings cover powered surgical drilling equipment classified within neurology. The supplied collection holds two linked 510(k) records, both with a Substantially Equivalent decision, and no recall records. Those counts describe the supplied filings as of the snapshot date, not total company sales, total portfolio or safety performance. [1][2][3]
Two same-day clearances for powered drilling devices
K254174 covers a device named Surgical Power System under product code HBC, regulation number 882.4360, with the classification name Motor, Drill, Electric. The record shows a Traditional submission received 23 December 2025 and decided 11 September 2026 as Substantially Equivalent, reviewed by the Neurology panel and not by a third party. A summary is listed as available. [1][3][6]
K254177 covers a device named Disposable Sterile Skull Drill (LZ) under product code HBF, regulation number 882.4305, with the classification name Drills, Burrs, Trephines & Accessories (Compound, Powered). It shares the same receipt date of 23 December 2025, the same 11 September 2026 Substantially Equivalent decision, Neurology panel assignment, Traditional type and non-third-party review. [2][4]
Filing scope and classification detail
Both records list device class 2 and Neurology as the medical specialty and review panel. Neither record indicates a combination product or an authorized predetermined change control plan. The K254174 classification page lists subsequent product codes EQJ, ERL, HBE, HBF and HWE alongside the primary HBC code, which places the two clearances in adjacent classification territory rather than unrelated device families. [3][4]
The applicant address on both FDA records is in Zunyi, postal code 563200, with the contact listed as Chang Feng Liu. That address is a filing address in the FDA data and is not treated here as a verified corporate headquarters. [1][2]
Relationship to the Nanos Medical group
A group sub-brands page published by Nanos Medical lists Guizhou Zirui Technology Co., Ltd. among its manufacturing centre entities, alongside Chengdu Mechan Electronic Technology Co., Ltd., Tonglu Sike Medical Instrument Co., Ltd., Suzhou Nanos Medical Instrument Co., Ltd. and Nanos Biomaterial (Suzhou) Co., Ltd. The same page lists Nanos Zirui Medical Technology (Shanghai) Co., Ltd. under its marketing centre. [5]
Nanos Medical's own company profile describes Nanos Medical (Shanghai) Limited as founded in 2015 and headquartered in Shanghai, focused on otorhinolaryngology and minimally invasive surgery, and states that it completed Series E financing in 2025. Those statements are attributed to that publisher and describe the group brand, not the FDA applicant's own corporate details. [8]
What the records do and do not establish
The supplied collection contains two 510(k) records, both decided Substantially Equivalent, and no recall entries. The smaller record sample used for filing examples is the same two clearances, so the sample and collection counts coincide here; neither figure speaks to total company sales, total portfolio or safety performance. [1][2]
The records identify cleared device names, product codes, regulation numbers, submission type and decision dates. They do not establish manufacturing sites, commercial availability, customers, certifications or clinical performance, and no such details are asserted here. [3][4]


